CME Group Inc.
CME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $6 | $5 | $5 |
| % Growth | 9.9% | 11.1% | 7% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $5 | $5 | $4 | $4 |
| % Margin | 86.1% | 85.1% | 85% | 82.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $4 | $3 | $3 | $3 |
| % Margin | 64.1% | 61.6% | 60.1% | 56.4% |
| Other Income/Exp. Net | $1 | $1 | $0 | $1 |
| Pre-Tax Income | $5 | $4 | $3 | $3 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $4 | $3 | $3 | $3 |
| % Margin | 57.5% | 57.8% | 53.6% | 56.2% |
| EPS | 9.69 | 8.87 | 7.41 | 7.3 |
| % Growth | 9.2% | 19.7% | 1.5% | – |
| EPS Diluted | 9.67 | 8.86 | 7.4 | 7.29 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $5 | $5 | $4 | $4 |
| % Margin | 82.2% | 83.6% | 80% | 83.7% |